Clinical-Microbiomics A/S: Financial statements 2017
CVR: 37230634
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Clinical-Microbiomics A/S (CVR 37230634) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 1,421,891 and a net result of DKK -4,377,471. Equity in the 2017 report amounted to DKK -3,770,611. The company had 9 employees in the financial year.
- Gross Profit
- DKK 1,421,891
- Profit/Loss
- DKK -4,377,471
- Equity
- DKK -3,770,611
- Total Assets
- DKK 3,736,925
- Employees
- 9
Official annual report
Keep an eye on Clinical-Microbiomics A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of October 29, 2017, Morten Otto Alexander Sommer has joined the board of directors of Clinical-Microbiomics A/S.
As of October 29, 2017, Ole Skov has left the board of directors of Clinical-Microbiomics A/S.
As of October 28, 2017, Morten Otto Alexander Sommer has left the board of directors of Clinical-Microbiomics A/S.
Clinical-Microbiomics A/S has published its interim report for the period November 2, 2015 – December 31, 2016.
About Clinical-Microbiomics A/S
Clinical-Microbiomics A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Clinical-Microbiomics ApS. The management consists of Anders Christian Neto de Sousa Grøn. The board consists of Manoj Nirmal Dadlani (chair), Bruce Harvey Grant, Caroline Popper and Isabelle Valerie de Cremoux. The company's owners include MANJIN ApS, VENDLER ApS and Health For Life Capital II Prima S.C.A. RAIF. The company has 32 employees (2026). In 2025, the company reported a gross profit of EUR 2,831,000 and a net result of EUR -2,586,000 compared with EUR -4,328,000 the year before. Equity in the 2025 report amounted to EUR 85,447,000.